Novartis15d
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...
ENDPOINTS NEWS21d
No­var­tis en­ters fight against HHS for deny­ing its 340B re­bate mod­el
No­var­tis is the lat­est drug­mak­er to sue the gov­ern­ment for al­leged­ly re­ject­ing its pro­posed mod­el to dis­trib­ute fed­er­al drug dis­counts.
Yahoo Finance22d
Novartis wins temporary pause to Entresto generic launch in US
WASHINGTON -A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' blockbuster heart-failure drug Entresto late on Wednesday.
Reuters22d
Novartis wins temporary pause to Entresto generic launch in US
WASHINGTON, Jan 15 - A federal appeals court temporarily paused drugmaker MSN Pharmaceuticals' launch of a generic version of Novartis' (NOVN.S), opens new tab blockbuster heart-failure drug ...
Reuters22d
US appeals court reinstates pause on generic version of Novartis' Entresto
WASHINGTON, Jan 16 - Novartis (NOVN.S), opens new tab won an order from a U.S. appeals court in Washington on Thursday temporarily blocking drugmaker MSN Pharmaceuticals from launching a generic ...
Daily22d
Novartis Entresto US patent upheld by US Court of Appeals
Basel: Novartis has announced that the Company is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the ...
Yahoo Finance25d
Novartis Entresto® US patent upheld by US Court of Appeals
Basel, January 13, 2025 – Novartis is pleased with the decision by the US Court of Appeals for the Federal Circuit (CAFC) that affirms the validity of the Entresto ® (sacubitril/valsartan ...
news.bloomberglaw27d
Novartis' Entresto Patent Revived in Federal Circuit Ruling
Ruling reverses Delaware judge who axed patent in mid-2023 Patent covers Novartis heart drug with billions in sales The Federal Circuit reversed a Delaware district court’s 2023 ruling axing a ...
Architectural Record28d
At MIT, SANAA Shapes a Music Building Among Midcentury Icons with Respectful Irreverence
SANAA’s much anticipated Edward and Joyce Linde Music Building officially opens its doors to the public next month—for Kazuyo Sejima and Ryue Nishizawa, their fourth building in the United States.
Pharmaceutical Technology28d
Light Horse emerges with $62m and Novartis partnership worth up to $1bn
Image credit: Shutterstock/ Hyejin Kang. Light Horse Therapeutics has galloped on to the biotech scene with $62m in Series A financing and a multi-target collaboration with Novartis that will see the ...
FierceBiotech28d
Light Horse lassos Novartis partnership worth up to $1B, wrangles $62M series A
Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that could reach up to $1 billion in biobucks. The San Diego-based biotech ...